IBC2:XETRA:XETRA-iShares II Public Limited Company - iShares $ High Yield Corporate Bond UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 3.9687

Change

-0.01 (-0.30)%

Market Cap

USD 0.28B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.08 (-0.14%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.22%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.06 (-0.22%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.13 (+0.52%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.42 (-0.91%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-1.58 (-1.10%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.09%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.08 (+0.07%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.82 (+0.13%)

USD 80.38B

ETFs Containing IBC2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.60% 37% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.60% 37% F 37% F
Trailing 12 Months  
Capital Gain -0.32% 13% F 21% F
Dividend Return 6.28% 96% N/A 91% A-
Total Return 5.96% 34% F 39% F
Trailing 5 Years  
Capital Gain -18.29% 9% A- 19% F
Dividend Return 22.81% 96% N/A 87% B+
Total Return 4.52% 31% F 35% F
Average Annual (5 Year Horizon)  
Capital Gain -3.10% 13% F 16% F
Dividend Return -2.87% 13% F 15% F
Total Return 0.23% 28% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 7.36% 75% C 80% B-
Risk Adjusted Return -38.97% 13% F 13% F
Market Capitalization 0.28B 52% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.